Basaco, T.; Pektor, S.; Bermudez, J.M.; Meneses, N.; Heller, M.; Galván, J.A.; Boligán, K.F.; Schürch, S.; Von Gunten, S.; Türler, A.;
et al. Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo. Pharmaceuticals 2018, 11, 132.
https://doi.org/10.3390/ph11040132
AMA Style
Basaco T, Pektor S, Bermudez JM, Meneses N, Heller M, Galván JA, Boligán KF, Schürch S, Von Gunten S, Türler A,
et al. Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo. Pharmaceuticals. 2018; 11(4):132.
https://doi.org/10.3390/ph11040132
Chicago/Turabian Style
Basaco, Tais, Stefanie Pektor, Josue M. Bermudez, Niurka Meneses, Manfred Heller, José A. Galván, Kayluz F. Boligán, Stefan Schürch, Stephan Von Gunten, Andreas Türler,
and et al. 2018. "Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo" Pharmaceuticals 11, no. 4: 132.
https://doi.org/10.3390/ph11040132
APA Style
Basaco, T., Pektor, S., Bermudez, J. M., Meneses, N., Heller, M., Galván, J. A., Boligán, K. F., Schürch, S., Von Gunten, S., Türler, A., & Miederer, M.
(2018). Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo. Pharmaceuticals, 11(4), 132.
https://doi.org/10.3390/ph11040132